AIRWA INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AIRWA INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Mar 7, 2023 | $15.00M | Jul 25, 2024 |
| FY2019 | Apr 30, 2019 | $0 | Aug 6, 2019 |
| FY2019 | Apr 30, 2018 | $13.2K | Aug 6, 2019 |
| FY2018 | Apr 30, 2017 | $14.7K | Aug 14, 2018 |
| FY2017 | Apr 30, 2016 | $0 | Aug 3, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $12.82M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $5.20M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $9.92M | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $16.10M | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | $10.80M | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | $686.2K | Aug 6, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $9.84M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $4.02M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $2.78M | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $4.22M | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | $3.12M | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | ($684.7K) | Aug 6, 2021 |
| FY2018 | Apr 30, 2018 | $13.2K | Aug 14, 2018 |
| FY2018 | Apr 30, 2017 | $14.7K | Aug 14, 2018 |
| FY2017 | Apr 30, 2016 | $0 | Aug 3, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $3.49M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $2.63M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | ($71.15M) | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | ($51.77M) | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | ($18.59M) | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | ($9.23M) | Aug 6, 2021 |
| FY2020 | Apr 30, 2019 | ($28.3K) | Aug 24, 2020 |
| FY2019 | Apr 30, 2018 | ($7.8K) | Aug 6, 2019 |
| FY2018 | Apr 30, 2017 | $3.8K | Aug 14, 2018 |
| FY2018 | Apr 30, 2016 | ($814) | Aug 14, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $6.58M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $3.85M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | ($21.96M) | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | ($46.71M) | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | ($3.73M) | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | ($6.92M) | Aug 6, 2021 |
| FY2020 | Apr 30, 2019 | ($28.3K) | Aug 24, 2020 |
| FY2019 | Apr 30, 2018 | ($7.8K) | Aug 6, 2019 |
| FY2018 | Apr 30, 2017 | $3.8K | Aug 14, 2018 |
| FY2017 | Apr 30, 2016 | ($814) | Aug 3, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Apr 30, 2023 | $65.2K | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $736.1K | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | $339.4K | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | $180.0K | Aug 6, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Apr 30, 2018 | $4.0K | Aug 14, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($379.4K) | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $39.4K | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | ($6.37M) | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | ($12.37M) | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | ($4.52M) | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | ($4.21M) | Aug 6, 2021 |
| FY2020 | Apr 30, 2019 | ($27.8K) | Aug 24, 2020 |
| FY2019 | Apr 30, 2018 | ($9.1K) | Aug 6, 2019 |
| FY2018 | Apr 30, 2017 | $9.3K | Aug 14, 2018 |
| FY2017 | Apr 30, 2016 | ($814) | Aug 3, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Apr 30, 2017 | ($3.0K) | Aug 14, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $32.91M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $23.16M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $7.11M | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $74.86M | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | $5.70M | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | $1.38M | Aug 6, 2021 |
| FY2020 | Apr 30, 2019 | $5.1K | Aug 24, 2020 |
| FY2019 | Apr 30, 2018 | $26.5K | Aug 6, 2019 |
| FY2018 | Apr 30, 2017 | $19.4K | Aug 14, 2018 |
| FY2017 | Apr 30, 2016 | $5.1K | Aug 3, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $6.49M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $1.44M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $25.72M | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $42.35M | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | $24.15M | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | $6.37M | Aug 6, 2021 |
| FY2020 | Apr 30, 2019 | $11.3K | Aug 24, 2020 |
| FY2019 | Apr 30, 2018 | $26.5K | Aug 6, 2019 |
| FY2018 | Apr 30, 2017 | $7.0K | Aug 14, 2018 |
| FY2017 | Apr 30, 2016 | $914 | Aug 3, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $25.28M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $21.72M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | ($18.61M) | Jul 25, 2024 |
| FY2023 | Jan 31, 2023 | $11.70M | Apr 10, 2024 |
| FY2024 | Apr 30, 2022 | $32.51M | Jul 25, 2024 |
| FY2023 | Apr 30, 2021 | ($18.45M) | Apr 10, 2024 |
| FY2022 | Apr 30, 2020 | ($4.99M) | Jul 18, 2023 |
| FY2021 | Apr 30, 2019 | ($6.2K) | Aug 6, 2021 |
| FY2020 | Apr 30, 2018 | $23.3K | Aug 24, 2020 |
| FY2019 | Apr 30, 2017 | $12.4K | Aug 6, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2022 | $6.78M | Apr 10, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $6.12M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $2.63M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | ($151.75M) | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | ($80.60M) | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | ($28.82M) | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | ($10.23M) | Aug 6, 2021 |
| FY2020 | Apr 30, 2019 | ($33.1K) | Aug 24, 2020 |
| FY2019 | Apr 30, 2018 | ($4.8K) | Aug 6, 2019 |
| FY2018 | Apr 30, 2017 | $3.0K | Aug 14, 2018 |
| FY2017 | Apr 30, 2016 | ($814) | Aug 3, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $54.7K | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | $39.4K | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | $202.1K | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | $665.0K | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | $928.8K | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | $79.8K | Aug 6, 2021 |
| FY2019 | Apr 30, 2019 | $2.0K | Aug 6, 2019 |
| FY2019 | Apr 30, 2018 | $20.8K | Aug 6, 2019 |
| FY2018 | Apr 30, 2017 | $16.0K | Aug 14, 2018 |
| FY2018 | Apr 30, 2016 | $5.1K | Aug 14, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | (5,084) | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | (13) | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | (6) | Jul 18, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Apr 30, 2024 | (32) | Jul 25, 2024 |
| FY2024 | Apr 30, 2023 | (5,084) | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | (13) | Apr 10, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 14.56M | Aug 13, 2025 |
| FY2025 | Apr 30, 2024 | 1.83M | Aug 13, 2025 |
| FY2024 | Apr 30, 2023 | 16,929 | Jul 25, 2024 |
| FY2023 | Apr 30, 2022 | 4.19M | Apr 10, 2024 |
| FY2022 | Apr 30, 2021 | 2.76M | Jul 18, 2023 |
| FY2021 | Apr 30, 2020 | 24.75M | Aug 6, 2021 |
| FY2020 | Apr 30, 2019 | 24.38M | Aug 24, 2020 |
| FY2019 | Apr 30, 2018 | 6.16M | Aug 6, 2019 |
| FY2018 | Apr 30, 2017 | 5.22M | Aug 14, 2018 |
| FY2017 | Apr 30, 2016 | 5.00M | Aug 3, 2017 |